Lexeo Therapeutics is a clinical-stage genetic medicine company focused on pioneering therapies for inherited cardiovascular diseases. Our lead program targets cardiomyopathy linked to Friedreich’s Ataxia, while we also tackle a range of genetically defined conditions, leveraging innovative science to drive impactful clinical solutions.
No jobs found. Subscribe below to get notified when we find something for you.
Searching